WEDNESDAY, Sept. 6, 2017 (HealthDay News) — The inhaler medication Spiriva (tiotropium bromide) may help slow the progression of COPD if given in the early stages of the disease, a new study suggests.

Researchers found that the drug helped patients preserve more lung function over two years. It also cut down on symptom flare-ups and boosted patients’ quality of life, on average.

All of the study patients were in the early stages of chronic obstructive pulmonary disease, or COPD — a group…

Continue reading on Health

Leave a Reply

Your email address will not be published.